关节炎
类风湿性关节炎
医学
炎症
基质金属蛋白酶
肿瘤坏死因子α
免疫系统
细胞外基质
软骨
癌症研究
骨关节炎
免疫学
口服
促炎细胞因子
信号转导
药理学
激酶
细胞因子
小RNA
自身免疫性疾病
滑膜
II型胶原
白细胞介素
受体
趋化因子
MMP9公司
金属蛋白酶
蛋白激酶A
炎性关节炎
滑液
酪氨酸激酶
作者
Hiroki Kaneta,Tomoyuki Nakasa,Dilimulati Yimiti,Dan Moriwaki,Riku Kawasaki,Toshihiko Ogura,Shigeru Miyaki,Nobuo Adachi
标识
DOI:10.1016/j.omtn.2026.102840
摘要
Ginger-derived extracellular vesicles (GDEVs) have emerged as a novel anti-inflammatory agent with advantages such as oral bioavailability, natural origin, and cost-effective large-scale production. This study evaluated the therapeutic potential of GDEVs in rheumatoid arthritis (RA), a chronic autoimmune disease characterized by synovial inflammation and joint destruction. We conducted both in vitro and in vivo experiments using synovial fibroblasts derived from RA patients and a collagen antibody-induced arthritis (CAIA) mouse model. In vitro , GDEVs significantly suppressed the expression of pro-inflammatory cytokines tumor necrosis factor-α (TNF-α) and interleukin (IL)-1β and downstream mediators IL-6, Cox-2, and matrix metalloproteinase 3 (MMP3) and inhibited the proliferation and migration of RA synovial fibroblasts. In vivo , oral administration of GDEVs to CAIA mice reduced arthritis severity, attenuated synovitis, preserved cartilage integrity, and suppressed osteoclast activation. GDEVs were stable against gastric digestion and were efficiently taken up by intestinal cells, supporting their oral availability. Microarray and RNA sequencing identified miR-149 as a key regulatory molecule in GDEVs, associated with the suppression of inflammation-related signaling pathways, including Ras signaling and mitogen-activated protein kinase (MAPK) cascades. These findings highlight the potential of GDEVs as an anti-inflammatory therapy for RA. Given their stability and bioavailability, the oral administration of GDEVs could be a promising non-invasive treatment for future clinical applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI